STUDY: COVID-19 Spike Proteins Help Cancer Cells Survive and RESIST Chemotherapy

STUDY: COVID-19 Spike Proteins Help Cancer Cells Survive and RESIST Chemotherapy


A new preprint cell study from Brown University has found that the spike protein from SARS-CoV-2, the virus responsible for the Wuhan coronavirus (COVID-19), helps cancer cells survive and resist chemotherapy.

Article by Laura Harris, republished with permission from Naturalnews.com

According to the study, led by Dr. Wafik El-Deiry, the director of Brown’s Legorreta Cancer Centerspike protein may promote cancer survival and growth through interference with anti-cancer activities, blocking the function of a crucial cancer suppressor gene known as p53.

Trending: Out-of-State Officials Storm Rudy Giuliani’s 80th Birthday Party, Indict Him in Front of Startled Guests: Report

El-Deiry and his colleagues observed that when cancer cells encountered spike protein subunits, it reduced the activity of p53, a protein that helps defend the body against tumors. This allowed the cancer cells to escape the body’s natural defenses against tumor formation. El-Deiry also explained that interfering with p53 can both foster

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!